Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Home Equity Loan Rates Hold Near 2026 Lows as Homeowners Delay Renovations Amid Geopolitical Uncertainty Stratasys Acquires MarkForged in 425 Million AllCash Deal Visa Highlights How AI Is Amplifying Financial Scams in Latest Threats Report China Against Everybody The New Geopolitics of Rare Earth Elements DR Congo Ebola Suspicion Red Cross Volunteers Deaths Raise Humanitarian and Regional Concerns STLD Q1 2026 Earnings EPS Misses Estimates Amidst Strong Steel Demand IBKR Q1 2026 Earnings Earnings Miss Expectations Amid Volatile Markets NXPI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction GCTS Q1 2026 Earnings EPS Misses Estimates Slightly as PreRevenue Semiconductor Firm Reports Narrow Loss OP Bancorp OPBK Q1 2026 Earnings EPS Surges Past Estimates Despite Modest Share Pullback Nkarta Inc NKTX Advances 425 as Biotech Sector Momentum Builds Valneva Shares Edge Higher as Price Action Tests Key Resistance Levels Ultra Clean Holdings UCTT Jumps 44 Approaching Key Resistance Zone Galectin Therapeutics GALT Holds Near 250 After Modest Decline Waymo Pauses Robotaxi Operations in Five US Cities Following FloodRelated Incidents Innovations That Redefined Daily Life A Look at 20 Companies Behind Indispensable Products Legal Challenges Emerge Against Trump Administrations Lawfare Compensation Fund US Government Stake Speculation Swirls Around IonQ Micron and Anduril After Quantum Moves Elon Musk Warns China Leads Humanoid Robot Competition as Workforce Integration Accelerates GRND Q4 2025 Earnings EPS Miss Amid Flat Revenue Disclosure Stock Slips Walmart CFO Notes Consumer Stress as High Fuel Prices Reduce Visits and Gallons Per FillUp CHT Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Environment Teo Siong Seng Shipping Tycoon Under Scrutiny Over Container PriceFixing Allegations CVKD Q1 2026 Earnings Narrowing Losses and Steady Progress in Clinical Pipeline